Chugai Pharmaceutical Co., Ltd. (CHGCY)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	68,009	73,254	62,351	42,013	53,339	87,648
Market Cap Growth	46.81%	17.49%	48.41%	-21.23%	-39.15%	72.61%
Enterprise Value	61,038	67,877	57,961	37,878	49,894	84,559
Last Close Price	20.05	21.97	18.85	12.67	16.36	26.60
PE Ratio	24.81	29.74	27.00	14.80	20.27	42.13
PS Ratio	8.20	9.84	7.91	4.40	6.14	11.50
PB Ratio	4.94	6.06	5.41	3.89	5.17	9.23
P/TBV Ratio	5.03	6.11	5.47	3.96	5.27	9.46
P/FCF Ratio	24.82	29.00	26.01	30.53	28.74	61.12
P/OCF Ratio	21.23	25.73	21.44	22.70	21.96	44.12
EV/Sales Ratio	7.52	9.12	7.35	3.97	5.75	11.09
EV/EBITDA Ratio	15.28	18.60	17.35	8.85	12.69	26.32
EV/EBIT Ratio	16.15	19.69	18.60	9.37	13.62	28.97
EV/FCF Ratio	22.27	26.87	24.17	27.52	26.89	58.97
Debt / Equity Ratio	-	0.01	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	-	0.02	0.03	0.02	0.04	0.03
Debt / FCF Ratio	-	0.03	0.04	0.08	0.08	0.08
Asset Turnover	0.55	0.56	0.59	0.74	0.72	0.69
Inventory Turnover	1.41	1.32	1.46	1.90	1.72	1.55
Quick Ratio	5.01	4.59	3.68	2.40	2.53	2.68
Current Ratio	6.04	5.53	4.74	3.15	3.25	3.54
Return on Equity (ROE)	21.16%	21.96%	21.34%	28.67%	27.95%	23.42%
Return on Assets (ROA)	16.05%	16.36%	14.44%	19.56%	19.01%	16.41%
Return on Capital (ROIC)	18.64%	19.08%	17.84%	25.23%	24.02%	20.27%
Return on Capital Employed (ROCE)	27.70%	28.30%	26.70%	36.90%	34.80%	30.10%
Earnings Yield	4.03%	3.36%	3.70%	6.76%	4.93%	2.37%
FCF Yield	4.03%	3.45%	3.84%	3.28%	3.48%	1.64%
Dividend Yield	6.83%	2.84%	3.01%	4.67%	4.04%	2.00%
Payout Ratio	40.86%	34.40%	40.43%	36.91%	32.56%	42.58%
Buyback Yield / Dilution	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.03%
Total Shareholder Return	6.83%	2.83%	3.00%	4.66%	4.03%	1.97%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.